Skip to Main Content
TRC_PTLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • First-Time Generics
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Psychiatry
  4. Resources
  5. Drugs

Drugs

  • ADHD (19)
  • Anxiety (18)
  • Bipolar Disorder (7)
  • Depression (78)
  • Mental Health (18)
  • Resources (68)
    • Charts (29)
    • Drugs (22)
      • Anti-Anxiety Drugs (3)
      • Antidepressants (8)
      • Antipsychotics (14)
      • Mood Stabilizers (2)
    • Guidelines (1)
    • Patient Education (3)
    • PL Voices (25)
    • Quality Measures (3)
  • Schizophrenia (27)
  • Sleep Disorders (33)
  • Substance Use Disorder (102)
1 - 15 of 22 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Aripiprazole (Abilify Asimtufii LA injectable)
April 2025
Chart: Drugs With Prescribing, Dispensing, or REMS Requirements
September 2024
Article: Watch Out for Gepirone ER on Home Med Lists June 2024
Article: Ensure Safety With Long-Acting Injectable Antipsychotics November 2023
Chart: Comparison of Atypical Antipsychotics (Canada) October 2023
Chart: Combining and Augmenting Antidepressants August 2023
Chart: Management of Acute Agitation and Delirium in Adults July 2023
Article: Watch for Mishaps With Meds for Depression June 2023
Algorithm: Drug-Induced QT Prolongation: A Stepwise Approach
August 2022
Article: Some Patients Will Take Antidepressant Combos July 2022
Article: Watch for Lybalvi, a New Combo Antipsychotic January 2022
Chart: Pharmacotherapy of Post-Traumatic Stress Disorder (PTSD) June 2021
Article: Expect Caplyta and Secuado to Continue on Admission April 2020
Toolbox: Preventing and Treating Delirium in Inpatients January 2019
Article: Aristada Initio and Perseris Will Be the Latest Injectable Antipsychotics October 2018
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved